ライフサイエンスコーパス: sulforhodamine

1 able to encapsulate small molecules such as sulforhodamine.

2 The fluorescent dyes sulforhodamine 101 (SR 101) and FM1-43 were used as acti

3 Sulforhodamine 101 (SR101) is a preferential astrocyte m

4 e used a sensitive activity-dependent probe, sulforhodamine 101 (SR101), to view endocytic events wit

5 cumulation of the fluorescent organic anions sulforhodamine 101 and fluorescein methotrexate was also

6 The method is based on the peroxyoxalate/sulforhodamine 101 chemiluminescence reaction, with SPE

7 Sulforhodamine 101 imaging showed that double fusion por

8 lm on the silver, the coupling efficiency of sulforhodamine 101 in PVA ranged from 30 to 49%.

9 The activity-dependent sulforhodamine 101 uptake after the trigeminal and hypog

10 green dye, calcein, and a reference red dye, sulforhodamine 101, after pulsed iontophoretic infusion.

11 es lacking a chelation site, fluorescein and sulforhodamine 101, implicating the fluorophore itself a

12 , combined with activity-dependent uptake of sulforhodamine 101, peripheral hypoglossal and trigemina

13 The astrocytic marker, sulforhodamine 101, stained the fusion-produced membrane

14 le-cell indicators of glutamate transport in sulforhodamine 101-positive astrocytes of Q175 mice, a k

15 , and astrocytes were selectively stained by sulforhodamine 101.

16 processes labeled by a Ca(2+) indicator and sulforhodamine 101.

17 d as uptake of the fluorescent optical probe sulforhodamine 101.

18 The introduction of sulforhodamine, a fluorophore that is not taken up by sy

19 es were expressed, labeled with bifunctional sulforhodamine, and exchanged into demembranated trabecu

20 Using sulforhodamine as a model hydrophilic drug, rates of dif

21 Sulforhodamine B (monosodium salt) exhibited a fold chan

22 The novel EPD delivered more than 80% sulforhodamine b (SRB) and model antigen ovalbumin (OVA)

23 somes both encapsulating the fluorescent dye sulforhodamine B (SRB) and with SRB tagged to lipids in

24 garding their growth inhibitory activity, by sulforhodamine B (SRB) assay.

25 Water-soluble sulforhodamine B (SRB) was loaded into the aqueous inter

26 lindrical PEO microdomains containing 10 muM sulforhodamine B (SRB) was prepared by directional solve

27 was to visualize the transdermal delivery of sulforhodamine B (SRB), a fluorescent hydrophilic permea

28 vaccine delivery as a much higher amount of sulforhodamine B (SRB), methylene blue (MB) or a model v

29 zol-2-yl)-2,5-diphenyltetrazolium bromide or sulforhodamine B analysis.

30 dimethylthiazol-2,5-diphenyl)tetrazolium and sulforhodamine B analysis] and interstrand DNA cross-lin

31 A combination of the sulforhodamine B and propidium iodide/Hoechst assays wou

32 Both sulforhodamine B and rhodamine B hexyl ester were observ

33 rophilic and hydrophobic fluorescent probes, sulforhodamine B and rhodamine B hexyl ester, in excised

34 Cell viability was measured by sulforhodamine B assay and also lactate dehydrogenase as

35 The sulforhodamine B assay gave valid results, but measures

36 and apoptotic effects) was determined by the sulforhodamine B assay, which measures the cellular prot

37 also evaluated in three cancer cell lines by sulforhodamine B assay.

38 anticancer drug-screening method based on a sulforhodamine B assay.

39 Based on sulforhodamine B assays for the number of viable cells,

40 ared and functionalized with rose bengal and sulforhodamine B by a ligand-exchange procedure.

41 T-tubules were visualized with sulforhodamine B dye.

42 s derived from the ortho and para isomers of sulforhodamine B fluorophores and demonstrated they are

43 ransport properties of the hydrophilic probe sulforhodamine B included increases in the vehicle to sk

44 mers with a precisely core positioned single sulforhodamine B molecule.

45 Cell growth inhibition was measured with the sulforhodamine B protein dye assay.

46 rmined in HeLa, MCF7 and MRC-5 cell lines by sulforhodamine B test.

47 lar mass fluorescent dyes Lucifer Yellow and Sulforhodamine B with the single vessel occlusion techni

48 ol) and two model compounds (fluorescein and sulforhodamine B) from porous media following evaporatio

49 ion (percent leakage of the fluorescent dye, Sulforhodamine B) over the entire studied concentration

50 l ester, and of the model hydrophilic probe, sulforhodamine B, for this 400-skin-site study exhibited

51 gged liposomes encapsulating the marker dye, sulforhodamine B.

52 delivery of two model fluorescent molecules, sulforhodamine-B and FITC-insulin in vitro, and absorpti

53 ose-dependent permeation of FITC-insulin and sulforhodamine-B.

54 Sulforhodamine-containing vesicles were shown by fluores

55 etected at distances of 5 and 10 mm from the sulforhodamine donor reservoir at 4 hours and 3 days, re

56 A new type of a highly fluorescent sulforhodamine dye, 221SR, was designed and synthesized

57 is study shows that the lateral diffusion of sulforhodamine in human sclera is slow and localizes to

58 h Fast Blue in the rat or activity-dependent sulforhodamine-labeled neurons in the turtle were used t

59 on in vivo and in vitro, we used fluorescent sulforhodamine-linked laminari-oligosaccharides as artif

60 ger cysteine-reactive methanethiosulfonates [sulforhodamine-methanethiosulfonate and 2-((biotinoyl)am

61 T were expressed in oocytes and labeled with sulforhodamine-MTS.

62 ll walls of this strain, when incubated with sulforhodamine-oligosaccharide, also showed Crhp-depende

63 ing polarized fluorescence from bifunctional sulforhodamine probes.

64 The effective lateral diffusivity of sulforhodamine was determined to be 3.82 x 10(-6) cm2/s,

65 Measurable amounts of sulforhodamine were detected at distances of 5 and 10 mm

66 lifetime-based nanoprobe based on lipophilic sulforhodamine, which stains 2D and 3D cell models, show